Cryptococcal cerebrospinal fluid shunt infection treated with fluconazole

Por Eymard, Daniel, Lebel, François
Publicado em 1993

Human herpesvirus 6 and chronic fatigue syndrome

Por Eymard, Daniel, Lebel, François, Miller, Mark, Turgeon, François
Publicado em 1993

IMMU-34. CONTROLLED EXPRESSION OF IL-12 IMPROVES SURVIVAL IN GLIOMA BY ACTIVATING THE IMMUNE RESPONSE IN MICE AND HUMANS

Por Barrett, John, Cai, Hongliang, Miao, John, Khare, Pranay, Chan, Tim, Cooper, Laurence, Lebel, Francois
Publicado no Neuro Oncol (2017)

PDCT-03. PHASE 1 STUDY OF Ad-RTS-hIL-12 + VELEDIMEX IN PEDIATRIC BRAIN TUMORS

Por Goldman, Stewart, Kieran, Mark, Mueller, Sabine, Buck, Jill, MacKenna, Richard, Barrett, John, Cooper, Laurence, Lebel, Francois
Publicado no Neuro Oncol (2017)

IMMU-33. CONTROLLED LOCAL EXPRESSION OF IL-12 AS GENE THERAPY CONCOMITANT WITH SYSTEMIC CHEMOTHERAPY IMPROVES SURVIVAL IN GLIOMA

Por Barrett, John, Cai, Hongliang, Miao, John, Khare, Pranay, Dalsing-Hernandez, Jessica, Gonzales, Paul, Chan, Tim, Cooper, Laurence, Lebel, Francois
Publicado no Neuro Oncol (2017)

ATIM-26. A PHASE 1 STUDY OF Ad-RTS-hIL-12 + VELEDIMEX IN ADULT RECURRENT GLIOBLASTOMA

Por Chiocca, E Antonio, Yu, John, Lukas, Rimas V, Buck, Jill, Demars, Nate, Barrett, John, Yang, Yijun, Cooper, Laurence, Lebel, Francois
Publicado no Neuro Oncol (2017)

Regulated intratumoral expression of IL-12 as a basis for combination therapy in melanoma

Por Nemunaitis, John J, Linette, Gerald P, Hamid, Omid, Agarwala, Sanjiv S, Starodub, Alexander, Sun, Lei, Lebel, Francois, Barrett, John A, Lewis, Jonathan
Publicado em 2014

Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System(®) (RTS(®)) gene switch as gene therapy for the treatment of glioma

Por Barrett, John A., Cai, Hongliang, Miao, John, Khare, Pranay D., Gonzalez, Paul, Dalsing-Hernandez, Jessica, Sharma, Geeta, Chan, Tim, Cooper, Laurence J.N, Lebel, Francois
Publicado no Cancer Gene Ther (2018)

ATIM-15. A PHASE 1 STUDY OF Ad-RTS-hIL-12 + VELEDIMEX IN ADULTS WITH RECURRENT GLIOBLASTOMA: DOSE DETERMINATION WITH UPDATED OVERALL SURVIVAL

Por Chiocca, E Antonio, Lukas, Rimas, Yu, John, Oberheim Bush, Nancy Ann, Buck, Jill, Demars, Nathan, Barrett, John, Gelb, Arnold, Wang, Yunxia, Cooper, Laurence, Lebel, Francois
Publicado no Neuro Oncol (2018)

IMPS-03 INTRATUMORAL REGULATED EXPRESSION OF IL-12 AS A GENE THERAPY APPROACH TO TREATMENT OF GLIOMA

Por Barrett, John A., Cai, Hongliang, Miao, John, Murray, Margaret, Gable, Emily, Blake, Deborhah, Krishnan, Suma, Chiocca, E. Antonio, Nagpal, Seema, Raizer, Jeffery, Yu, John, Lebel, Francois
Publicado no Neuro Oncol (2015)

Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial

Por Chiocca, E. Antonio, Yu, John S., Lukas, Rimas V., Solomon, Isaac H., Ligon, Keith L., Nakashima, Hiroshi, Triggs, Daniel A., Reardon, David A., Wen, Patrick, Stopa, Brittany M., Naik, Ajay, Rudnick, Jeremy, Hu, Jethro L., Kumthekar, Priya, Yamini, Bakhtiar, Buck, Jill Y., Demars, Nathan, Barrett, John A., Gelb, Arnold B., Zhou, John, Lebel, Francois, Cooper, Laurence J. N.
Publicado no Sci Transl Med (2019)